Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Clinical trial NCT07020065 · RECRUITING

Trial details

NCT number

NCT07020065

Sponsor

Swiss Cancer Institute

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2026-04-10

Primary completion

2028-09-01

Enrollment

156

View on ClinicalTrials.gov